Atrial Fibrillation Trial, Recruiting NCT07141745 Sponsor: Wroclaw Medical University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07141745
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had atrial fibrillation (AF) or an irregular heart rhythm called atypical atrial flutter return after a previous procedure to treat it (called pulmonary vein isolation, or PVI)
  • People whose heart condition makes them suitable for a repeat pulmonary vein isolation procedure, as determined by their treating doctor

Who may not be able to join:

  • People whose heart's main pumping chamber is working at less than 30% of its normal capacity
  • People whose left upper heart chamber (left atrium) is enlarged beyond a certain size, specifically a volume index greater than 72 mL/m² (confirm with trial site)
  • People who have an overactive thyroid gland that has not yet been treated
  • People who have a condition called hypertrophic cardiomyopathy, where the heart muscle is abnormally thick
  • People who have serious problems with one or more of their heart valves

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Wroclaw Medical University
Registry
ClinicalTrials.gov
Start date
30 August 2025
Est. completion
1 August 2028

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Freedom from atrial arrythmia in 12 month observation period

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov